Markets
← Back to Stocks
DXCM
DEXCOM INC
Health Care · Health Care Equipment
$67.29
-0.65%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
CGM focus shows strength despite modest pre-market weakness
DexCom closed Wednesday around $64.58 and declined 0.53% in after-hours, with pre-market at $66.06 down 1.23%. Rick Osterloh joined the board effective February 26, 2026, and the company presented at the Raymond James conference March 2, 2026. The continuous glucose monitoring sector shows strong growth fundamentals.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$26.2B
P/E (TTM)32.2
Forward P/E22.5
Beta1.53
Div Yield—
Prev Close$67.73
RSI (14-Day)
30Neutral
0305070100
52-Week Range
$54.11$67.29$89.98
From High-25.2%
From Low+24.4%
Moving Averages
50d SMA
$70.49-4.5%
200d SMA
$72.65-7.4%
Price below 200d MA — bearish structure.
Returns
1W
+3.1%
1M
-7.6%
3M
+1.4%
6M
-12.0%
1Y
-4.8%
YTD
+1.1%
Volume
Today43K
20d Avg3.9M
Ratio0.01x